Alerts will be sent to your verified email
Verify Email
WINDLAS
|
Windlas Biotech
|
Amrutanjan Healthcar
|
Syncom Formulations
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.77 % | 14.67 % | 8.81 % |
|
5yr average Equity Multiplier
|
1.41 | 1.41 | 1.5 |
|
5yr Average Asset Turnover Ratio
|
1.07 | 1.22 | 0.79 |
|
5yr Avg Net Profit Margin
|
6.87 % | 8.57 % | 7.78 % |
|
Price to Book
|
3.86 | 6.18 | 5.91 |
|
P/E
|
31.97 | 39.67 | 40.88 |
|
5yr Avg Cash Conversion Cycle
|
5.93 Days | 21.59 Days | 84.02 Days |
|
Inventory Days
|
40.6 Days | 23.18 Days | 27.61 Days |
|
Days Receivable
|
73.22 Days | 51.48 Days | 123.89 Days |
|
Days Payable
|
94.29 Days | 49.13 Days | 93.18 Days |
|
5yr Average Interest Coverage Ratio
|
41.19 | 27.21 | 39.83 |
|
5yr Avg ROCE
|
16.36 % | 24.07 % | 12.74 % |
|
5yr Avg Operating Profit Margin
|
12.16 % | 14.15 % | 9.47 % |
|
5 yr average Debt to Equity
|
0.06 | 0.12 | 0.2 |
|
5yr CAGR Net Profit
|
29.13 % | 16.38 % | 19.56 % |
|
5yr Average Return on Assets
|
7.07 % | 10.59 % | 5.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.34 % | 46.52 % | 50.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.39 % | -3.5 % | 4.45 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.8 % | 1.62 % | 0.0 |
|
Windlas Biotech
|
Amrutanjan Healthcar
|
Syncom Formulations
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Acute vs Chronic
|
Acute vs Chronic
|
-
|
-
|
|
Segment Wise Break-Up
|
Segment Wise Break-Up
|
-
|
-
|